Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Purpose: Recent evidence suggests that cancer stem cells (CSC) are responsible for key elements of colon cancer progression and recurrence. Germline variants in CSC genes may result in altered gene function and/or activity, thereby causing interindividual differences in a patient's tumor recurrence capacity and chemoresistance. We investigated germline polymorphisms in a comprehensive panel of CSC genes to predict time to tumor recurrence (TTR) in patients with stage III and high-risk stage II colon cancer. Experimental Design: A total of 234 patients treated with 5-fluorouracil–based chemotherapy at the University of Southern California were included in this study. Whole blood samples were analyzed for germline polymorphisms in genes that have been previously associated with colon CSC (CD44, Prominin-1, DPP4, EpCAM, ALCAM, Msi-1, ITGB1, CD24, LGR5, and ALDH1A1) by PCR-RFLP or direct DNA-sequencing. Results: The minor alleles of CD44 rs8193 C>T, ALCAM rs1157 G>A, and LGR5 rs17109924 T>C were significantly associated with increased TTR (9.4 vs. 5.4 years; HR, 0.51; 95% CI: 0.35–0.93; P = 0.022; 11.3 vs. 5.7 years; HR, 0.56; 95% CI: 0.33–0.94; P = 0.024, and 10.7 vs. 5.7 years; HR, 0.33; 95% CI: 0.12–0.90; P = 0.023, respectively) and remained significant in the multivariate analysis stratified by ethnicity. In recursive partitioning, a specific gene variant profile including LGR5 rs17109924, CD44 rs8193, and ALDH1A1 rs1342024 represented a high-risk subgroup with a median TTR of 1.7 years (HR, 6.71, 95% CI: 2.71–16.63, P < 0.001). Conclusion: This is the first study identifying common germline variants in colon CSC genes as independent prognostic markers for stage III and high-risk stage II colon cancer patients. Clin Cancer Res; 17(21); 6934–43. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification And Regression Trees
Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (2017) · doi:10.1201/9781315139470 · Cited by 11,417
Cited by
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Zeuner, A., Todaro, M., Stassi, G., & De Maria, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.012 · Cited by 368
LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence
Gong, X., Azhdarinia, A., Ghosh, S. C., Xiong, W., An, Z., Liu, Q., & Carmon, K. S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0114 · Cited by 130
Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer
Zhou, J.-Y., Chen, M., Ma, L., Wang, X., Chen, Y.-G., & Liu, S.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.7084 · Cited by 67
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Sato-Dahlman, M., Miura, Y., Huang, J. L., Hajeri, P., Jacobsen, K., Davydova, J., & Yamamoto, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18340 · Cited by 43
“Recent researches suggest that cancer stem cells (CSCs) are responsible for CRC recurrence and metastasis, and also associated with tumor growth, chemo- resistance [3, 4].”
Background
Metadata
- Authors
- Gerger, A., Zhang, W., Yang, D., Bohanes, P., Ning, Y., Winder, T., LaBonte, M. J., Wilson, P. M., Benhaim, L., Paez, D., El-Khoueiry, R., El-Khoueiry, A., Kahn, M., & Lenz, H.-J.
- Venue
- Clinical Cancer Research
- Published
- 2011-10-31
- Volume
- 17
- Issue
- 21
- Pages
- 6934-6943
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2138842322
- Cited by
- 99
- References
- 1
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-1180
- The paper
- Gerger, A., Zhang, W., Yang, D., Bohanes, P., Ning, Y., Winder, T., LaBonte, M. J., Wilson, P. M., Benhaim, L., Paez, D., El-Khoueiry, R., El-Khoueiry, A., Kahn, M., & Lenz, H.-J. (2011). Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-1180
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.